$1.39
In chiusura: Sep 29 EDT
$1.39
0.000.00%
Pre-mercato: 6:31 PM EDT
Comments
Loading...
Stime degli utili, EPS e fatturato
Lexicon Pharmaceuticals segnala gli utili su base trimestrale. Questi report sugli utili trimestrali offrono agli investitori uno sguardo ai risultati finanziari di un'azienda per un periodo di 3 mesi. I report sugli utili includono quasi sempre i risultati EPS e i ricavi.
Data degli utili
nov 11
Stima EPS
$-0.070
Stima dei ricavi trimestrali
$7.26M
Ricavi annuali
(a partire da giu 30)
(a partire da giu 30)
$58.43M
Analizza lo storico degli utili di Lexicon Pharmaceuticals utilizzando ordinamenti e filtri avanzati.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
LXRX | Lexicon Pharmaceuticals | -$0.18 | -$0.07 | — | — | $1.75M | $7.26M | — | — | 11/11/2025 | |
LXRX | Lexicon Pharmaceuticals | -$0.17 | -$0.08 | $0.01 | 112.50% | $1.65M | $5.52M | $28.87M | 423.27% | 08/06/2025 | |
LXRX | Lexicon Pharmaceuticals | -$0.20 | -$0.10 | -$0.07 | 30.00% | $1.13M | $2.12M | $1.26M | -40.47% | 05/13/2025 | |
LXRX | Lexicon Pharmaceuticals | -$0.20 | -$0.12 | -$0.09 | 25.00% | $702.00K | $6.48M | $26.55M | 309.78% | 03/06/2025 | |
LXRX | Lexicon Pharmaceuticals | -$0.21 | -$0.16 | -$0.18 | -12.50% | $162.00K | $2.93M | $1.75M | -40.27% | 11/12/2024 | |
LXRX | Lexicon Pharmaceuticals | -$0.22 | -$0.19 | -$0.17 | 10.53% | $317.00K | $2.83M | $1.65M | -41.80% | 08/01/2024 | |
LXRX | Lexicon Pharmaceuticals | -$0.17 | -$0.20 | -$0.20 | 0.00% | $24.00K | $1.37M | $1.13M | -17.52% | 05/02/2024 | |
LXRX | Lexicon Pharmaceuticals | -$0.16 | -$0.22 | -$0.20 | 9.09% | $28.00K | $1.24M | $702.00K | -43.39% | 03/11/2024 | |
LXRX | Lexicon Pharmaceuticals | -$0.13 | -$0.21 | -$0.21 | 0.00% | $39.00K | $2.06M | $162.00K | -92.14% | 11/08/2023 | |
LXRX | Lexicon Pharmaceuticals | -$0.16 | -$0.17 | -$0.22 | -29.41% | $35.00K | $70.00K | $317.00K | 352.86% | 08/03/2023 | |
LXRX | Lexicon Pharmaceuticals | -$0.16 | -$0.18 | -$0.17 | 5.56% | $37.00K | $30.00K | $24.00K | -20.00% | 05/02/2023 | |
LXRX | Lexicon Pharmaceuticals | -$0.17 | -$0.13 | -$0.16 | -23.08% | $14.00K | $50.00K | $28.00K | -44.00% | 03/02/2023 | |
LXRX | Lexicon Pharmaceuticals | -$0.16 | -$0.14 | -$0.13 | 7.14% | $23.00K | $50.00K | $39.00K | -22.00% | 11/09/2022 | |
LXRX | Lexicon Pharmaceuticals | -$0.13 | -$0.16 | -$0.16 | 0.00% | $234.00K | $50.00K | $35.00K | -30.00% | 08/02/2022 | |
LXRX | Lexicon Pharmaceuticals | -$0.15 | -$0.16 | -$0.16 | 0.00% | $27.00K | $50.00K | $37.00K | -26.00% | 05/05/2022 | |
LXRX | Lexicon Pharmaceuticals | -$0.04 | -$0.18 | -$0.17 | 5.56% | $199.00K | — | $14.00K | — | 02/28/2022 | |
LXRX | Lexicon Pharmaceuticals | -$0.43 | -$0.18 | -$0.16 | 11.11% | $6.63M | — | $23.00K | — | 11/03/2021 | |
LXRX | Lexicon Pharmaceuticals | -$0.65 | -$0.16 | -$0.13 | 18.75% | $9.16M | $10.00K | $234.00K | 2240.00% | 07/30/2021 | |
LXRX | Lexicon Pharmaceuticals | -$0.63 | -$0.16 | -$0.15 | 6.25% | $8.00M | $1.68M | $27.00K | -98.39% | 05/06/2021 | |
LXRX | Lexicon Pharmaceuticals | -$0.48 | -$0.28 | -$0.04 | 85.71% | $8.73M | $110.00K | $199.00K | 80.91% | 03/10/2021 | |
LXRX | Lexicon Pharmaceuticals | -$0.10 | $0.26 | -$0.43 | -265.38% | $294.45M | $16.87M | $6.63M | -60.68% | 10/29/2020 |
Lexicon Pharmaceuticals (LXRX) Guadagno per azione
Importo a sorpresa sugli utili trimestrali
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q2 | 2025-08-06 | $0.01 | $-0.08 | 112.5 % |
| Q1 | 2025-05-13 | $-0.07 | $-0.10 | 30.0 % |
| Q4 | 2025-03-06 | $-0.09 | $-0.12 | 25.0 % |
| Q3 | 2024-11-12 | $-0.18 | $-0.16 | -12.5 % |
Lexicon Pharmaceuticals (LXRX) Entrate
Importo sorpresa sulle entrate trimestrali
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q2 | 2025-08-06 | $28.87M | $5.52M | 423.3 % |
| Q1 | 2025-05-13 | $1.26M | $2.12M | -40.5 % |
| Q4 | 2025-03-06 | $26.55M | $6.48M | 309.8 % |
| Q3 | 2024-11-12 | $1.75M | $2.93M | -40.3 % |
FAQ
Quando Lexicon Pharmaceuticals (NASDAQ:LXRX) riporterà gli utili?
Si prevede che Lexicon Pharmaceuticals (LXRX) fornisca risultati il novembre 11, 2025. Gli ultimi risultati sono stati pubblicati il agosto 6, 2025 per il Q2.
Quali sono stati gli ultimi utili per azione (EPS) di Lexicon Pharmaceuticals (NASDAQ:LXRX)?
L'EPS effettivo era $0.01, che superato la stima di $-0.08.
Quali sono state le entrate di Lexicon Pharmaceuticals (NASDAQ:LXRX)?
Le entrate effettive sono state $28.9M, che superato la stima di $5.5M.
Sfoglia stime sugli utili, EPS e ricavi su tutte le azioni.